# What constitutes optimal care coordination for primary brain tumors and how do we assess it in Australia and Aotearoa New Zealand? A Delphi consensus study

**Authors:** Megan S Jeon, Sharon He, Joanne Shaw, Eng-Siew Koh, Brian Kelly, Mark B Pinkham, Dianne M Legge, Georgia K B Halkett, Raymond J Chan, Tamara Ownsworth, Ursula M Sansom-Daly, Marina Kastelan, Haryana M Dhillon, Megan S Jeon, Megan S Jeon, Sharon He, Joanne Shaw, Eng-Siew Koh, Brian Kelly, Mark B Pinkham, Dianne M Legge, Georgia K B Halkett, Raymond J Chan, Tamara Ownsworth, Ursula M Sansom-Daly, Marina Kastelan, Haryana M Dhillon

PMC · DOI: 10.1093/nop/npaf082 · 2025-08-04

## TL;DR

This study created a framework for optimal care coordination for people with primary brain tumors in Australia and New Zealand through a consensus process.

## Contribution

The study introduces a novel care coordination framework tailored specifically for primary brain tumor patients.

## Key findings

- Consensus was reached on 97 out of 140 items across four domains of care coordination.
- Panelist agreement varied for items related to healthcare system governance indicators.
- The final framework includes 136 items after incorporating 6 additional items based on feedback.

## Abstract

People with primary brain tumors (PBT) and their carers experience diverse issues and functional impairments, which can form barriers to accessing tailored health care. Care coordination (CC) addresses this dual challenge and is critical to achieving high-quality care for PBT. We aimed to develop a consensus framework and assessable quality indicators for optimal CC for PBT.

A 2-phase, modified Delphi process was conducted. In Phase 1, a preliminary framework of 4 domains and 140 items was identified from a scoping review and expert stakeholder advisory group discussion (n = 14). In Phase 2, multidisciplinary panel members (n = 40) with expertise in clinical management and support for PBT indicated level of agreement (consensus criteria: ≥80% agreement and a median score of ≥4) on proposed items using a 5-point Likert scale. The expert stakeholder advisory group finalized components and indicators based on panel consensus findings.

Consensus was achieved for 97/140 items across four domains (definition, objective, components, and indicators), and a further 33 items approached consensus following 2 survey rounds. Panelist ratings on quality indicators for CC varied, especially for items related to indicators of healthcare system governance (range 48%–79% agreement). The expert stakeholder advisory group finalized the inclusion of 6 additional items based on feedback from panelists, producing a final list of 136 items.

We defined a novel framework of CC specific to PBT, which presents a consensus-based definition and objectives for CC and comprehensive lists of components and quality indicators. The framework provides a useful template for developing models of CC.

## Full-text entities

- **Diseases:** breast, or lung cancer (MESH:D001943), functional impairment (MESH:D003072), Brain Tumor (MESH:D001932), neurological symptoms (MESH:D009461), CC (MESH:D001259), Glioma (MESH:D005910), Toxicity (MESH:D064420), Cancer (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12965651/full.md

---
Source: https://tomesphere.com/paper/PMC12965651